STOCK TITAN

Zeo ScientifiX (ZEOX) appoints Ian T. Bothwell as full-time CEO and CFO

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Zeo ScientifiX, Inc. announced a leadership change, making Ian T. Bothwell the company’s full-time Chief Executive Officer effective December 24, 2025. He had been serving as Interim Chief Executive Officer while also holding the role of Chief Financial Officer, and will continue in the dual position of Chief Executive Officer and Chief Financial Officer. This move formalizes the company’s executive leadership structure by confirming Bothwell as permanent CEO.

Positive

  • None.

Negative

  • None.
false 0001557376 0001557376 2025-12-24 2025-12-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): December 24, 2025

 

ZEO SCIENTIFIX, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   000-55008   47-4180540
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

3321 College Avenue, Suite 246
Davie, Florida

  33314
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (888) 963-7881

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
None   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

As used in this Current Report on Form 8-K (this “Report”), and unless otherwise indicated, the terms “the Company,” “ZEO,” “we,” “us” and “our” refer to Zeo ScientifiX, Inc.

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective December 24. 2025, ZEO’s board of directors appointed Ian T. Bothwell, who has been serving as ZEO’s Interim Chief Executive Officer in addition to Chief Financial Officer, as the Company’s full-time Chief Executive Officer. Mr. Bothwell will continue to serve as our Chief Financial Officer.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 5, 2026 ZEO SCIENTIFIX, INC.
     
  By: /s/ Ian T. Bothwell
   

Ian T. Bothwell

Chief Executive Officer and Chief Financial Officer

 

2

FAQ

What leadership change did Zeo ScientifiX (ZEOX) disclose in this filing?

Zeo ScientifiX, Inc. disclosed that its board of directors appointed Ian T. Bothwell as the company’s full-time Chief Executive Officer, effective December 24, 2025.

Who is the new full-time CEO of Zeo ScientifiX (ZEOX)?

The new full-time Chief Executive Officer of Zeo ScientifiX, Inc. is Ian T. Bothwell, who had been serving as Interim Chief Executive Officer.

Will Ian T. Bothwell remain Chief Financial Officer of Zeo ScientifiX (ZEOX)?

Yes. Ian T. Bothwell will continue to serve as Chief Financial Officer while also serving as the company’s full-time Chief Executive Officer.

When did Ian T. Bothwell’s appointment as full-time CEO of Zeo ScientifiX (ZEOX) become effective?

Ian T. Bothwell’s appointment as full-time Chief Executive Officer became effective on December 24, 2025.

What roles did Ian T. Bothwell hold at Zeo ScientifiX (ZEOX) before this appointment?

Before being appointed full-time Chief Executive Officer, Ian T. Bothwell served as Interim Chief Executive Officer and Chief Financial Officer of Zeo ScientifiX, Inc.

Does the Zeo ScientifiX (ZEOX) filing mention any other major corporate events?

The filing focuses on the appointment of Ian T. Bothwell as full-time Chief Executive Officer and confirms that he will continue as Chief Financial Officer.

ZEO ScientifiX

OTC:ZEOX

ZEOX Rankings

ZEOX Latest News

ZEOX Latest SEC Filings

ZEOX Stock Data

9.87M
3.56M
45.68%
Biotechnology
Healthcare
Link
United States
Davie